Related Experiment Video
Updated: Apr 3, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Enhancement patterns detected by multidetector computed tomography are associated with microvascular obstruction and
Hiroaki Watabe1, Akira Sato2, Hidetaka Nishina3
1Cardiovascular Division, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.
Insights
Heterogeneous enhancement on multidetector computed tomography (MDCT) after percutaneous coronary intervention (PCI) can predict microvascular obstruction and left ventricular remodelling in acute myocardial infarction (AMI) patients.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- Acute myocardial infarction (AMI) can lead to microvascular obstruction (MVO) and left ventricular (LV) remodelling.
- Assessing these post-AMI complications is crucial for patient management.
- Multidetector computed tomography (MDCT) is an imaging modality used in cardiology.
Purpose of the Study:
- To evaluate the clinical value of myocardial contrast-delayed enhancement (DE) with MDCT.
- To detect MVO and LV remodelling after AMI.
- To compare MDCT findings with DE magnetic resonance imaging (MRI).
Main Methods:
- MDCT with DE was performed in 92 patients post-AMI and successful percutaneous coronary intervention (PCI).
- DE magnetic resonance imaging (MRI) was used as a reference standard for MVO and LV remodelling.
- Patients were categorized based on heterogeneous enhancement (HE) patterns on MDCT.
Main Results:
- Heterogeneous enhancement (HE) and a relative CT density >2.20 were significant predictors of MVO.
- HE and relative CT density >2.20 demonstrated high positive (93%) and negative (90%) predictive values for MVO.
- HE was significantly associated with LV remodelling.
Conclusions:
- MDCT-detected heterogeneous enhancement shortly after primary PCI shows promise.
- This imaging technique can aid in predicting MVO and LV remodelling in AMI patients.
Aims:
This study evaluated the clinical value of myocardial contrast-delayed enhancement (DE) with multidetector computed tomography (MDCT) for detecting microvascular obstruction (MVO) and left ventricular (LV) remodelling revealed by DE magnetic resonance imaging after acute myocardial infarction (AMI).
Methods And Results:
In 92 patients with first AMI, MDCT without iodine reinjection was performed immediately following successful percutaneous coronary intervention (PCI). Delayed-enhancement magnetic resonance imaging performed in the acute and chronic phases was used to detect MVO and LV remodelling (any increase in LV end-systolic volume at 6 months after infarction compared with baseline). Patients were divided into two groups according to the presence (n = 33) or absence (n = 59) of heterogeneous enhancement (HE). Heterogeneous enhancement was defined as concomitant presence of hyper- and hypoenhancement within the infarcted myocardium on MDCT. Microvascular obstruction and LV remodelling were detected in 49 (53%) and 29 (32%) patients, respectively. In a multivariable analysis, HE and a relative CT density >2.20 were significant independent predictors for MVO [odds ratio (OR) 13.5; 95% confidence interval (CI), 2.15-84.9; P = 0.005 and OR 12.0; 95% CI, 2.94-49.2; P < 0.001, respectively). The presence of HE and relative CT density >2.20 showed a high positive predictive value of 93%, and the absence of these two findings yielded a high negative predictive value of 90% for the predictive value of MVO. Heterogeneous enhancement was significantly associated with LV remodelling (OR 6.75; 95% CI, 1.56-29.29; P = 0.011).
Conclusion:
Heterogeneous enhancement detected by MDCT immediately after primary PCI may provide promising information for predicting MVO and LV remodelling in patients with AMI.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies

